Research Paper Volume 1, Issue 12 pp 988—1007

Figure 4. Laboratory values of blood cell counts for case 3. (A) Neutrophils; (B) Lymphocytes; (C) White blood cells, WBC; (D) Platelets; (E) Red blood cells, RBC (F) Hemoglobin, Hgb; (G) Hematocrit, Hct; (H) Prostate specific antigen (PSA) level. The patient was enrolled in abiraterone acetate (CYP17 inhibitor) trial for 90 days indicated by vertical dash lines. The patient also received G-CSF (Neulasta) on the day of chemotherapy except during the treatment with abiraterone acetate. Filled triangle indicates day of chemotherapy; open square indicates fasting, arrow indicates testosterone application (cream 1%). Normal ranges of laboratory values are indicated by horizontal dash lines; (I) Self-reported side-effects after chemotherapy for case 3. Data represent the average of 5 cycles of chemo-alone vs the average of 7 cycles of chemo-fasting treatments.